Cannabis Bioscience International Holdings (CBIH) Share-based Compensation (2024 - 2025)

Cannabis Bioscience International Holdings' (CBIH) quarterly Share-based Compensation came in at $150000.0 in Q2 2025, up 294.77% year-on-year from $37997.0 in Q2 2024, and up 600.0% quarter-over-quarter from -$30000.0 in Q4 2024.

Cannabis Bioscience International Holdings (CBIH) Share-based Compensation (2024 - 2025) Analysis & Trends

Cannabis Bioscience International Holdings has disclosed Share-based Compensation across 2 years of filings, most recently posting $150000.0 for Q2 2025.

  • Share-based Compensation for Q2 2025 came in at $150000.0, up 294.77% year-over-year; the trailing twelve-month figure through Feb 2026 was $150000.0 (up 38.89% YoY), and the FY2025 annual result was $220000.0, up 94.7% from the prior year.
  • Share-based Compensation came in at $150000.0 for Q2 2025 at Cannabis Bioscience International Holdings, up from -$30000.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $150000.0 in Q2 2025 to a low of -$30000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 43.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 25.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 33.90 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -395,114.54
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 57.20 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 21.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 36.33 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 36.86 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 16.04 Mn
10 Cannabis Bioscience International Holdings - - 8,160.00 -

Historic Data

Download Data
DateValue
May 31, 2025 150,000.00
May 31, 2025 150,000.00
Nov 30, 2024 -30,000.00
Nov 30, 2024 -30,000.00
Aug 31, 2024 100,000.00
Aug 31, 2024 100,000.00
May 31, 2024 37,997.00
May 31, 2024 37,997.00